Delta-sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches

  1. Lookup NU author(s)
  2. Dr Alison Blain
  3. Professor Volker Straub
Author(s)Straub VW; Blain AM
Publication type Review
JournalSkeletal Muscle
Year2011
Volume1
Issue1
Pages13
ISSN (electronic)2044-5040
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Mutations in the δ-sarcoglycan gene cause limb-girdle muscular dystrophy 2F (LGMD2F), an autosomal recessive disease that causes progressive weakness and wasting of the proximal limb muscles and often has cardiac involvement. Here we review the clinical implications of LGMD2F and discuss the current understanding of the putative mechanisms underlying its pathogenesis. Preclinical research has benefited enormously from various animal models of δ-sarcoglycan deficiency, which have helped researchers to explore therapeutic approaches for both muscular dystrophy and cardiomyopathy.
URLhttp://dx.doi.org/10.1186/2044-5040-1-13
DOI10.1186/2044-5040-1-13
Actions    Link to this publication